The abscopal effect of radiotherapy and nivolumab in relapsed or refractory Hodgkin lymphoma
The abscopal effect of radiotherapy and nivolumab in relapsed or refractory Hodgkin lymphoma
Quizartinib improves overall survival in adult patients with FLT3-ITD+ acute myeloid leukaemia
Adagrasib shows CNS penetration and encouraging intracranial activity for KRASG12C-mutated NSCLC and active, untreated CNS metastases
ASCO 2022: Head and neck cancer highlights
Comment: LUMINA results show that women with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy
Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Comment: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy
Momelotinib superior to danazol in symptomatic and anaemic myelofibrosis patients previously treated with a JAK inhibitor
Pembrolizumab demonstrates clinically meaningful improvement in distant metastasis-free survival in patients with melanoma
Elacestrant significantly prolongs PFS for ER+/HER2- metastatic breast cancer without prior chemotherapy patients
ASCO 2022: Breast cancer highlights
ASCO 2022: Latest in prostate cancer, including PARP inhibitors